Study title:
Nucl Med Commun. 2004 May;25(5):439-43.
18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary
thyroid carcinoma: a clinical study and an analysis of the literature.
Gotthardt M, Battmann A, HÃffken H, Schurrat T, Pollum H, Beuter D, Gratz S, Béhé
M, Bauhofer A, Klose KJ, Behr TM.
Type of medicine: Medicines containing chemical active substances
|
Therapeutic area: Diagnosis [E01]
|
Brands: Please see report |
MAH holders: Please see report |
Assessment: |
Active substance: FLUDEOXYGLUCOSE |
ATC code: |
Document link:
|
Document date:
|
Study number: |
EudraCT number:
|
Scope of study: Clinical |
Population of study subjects:
|
Preterm newborn Infants
|
Newborn infants
(1 to 27 days)
|
Infants and toddlers
(28 days to 24 months)
|
Children
(2 to 11 years)
|
Adolescents
(12 to 18 years)
|
|
-
|
-
|
-
|
Y
|
Y
|